Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.

ABSTRACT:

Background

IBM Watson for Oncology (WFO), which can use natural language processing to evaluate data in structured and unstructured formats, has begun to be used in China. It provides physicians with evidence-based treatment options and ranks them in three categories for treatment decision support. This study was designed to examine the concordance between the treatment recommendation proposed by WFO and actual clinical decisions by oncologists in our cancer center, which would reflect the differences of cancer treatment between China and the U.S.

Patients and methods

Retrospective data from 362 patients with cancer were ingested into WFO from April 2017 to October 2017. WFO recommendations were provided in three categories: recommended, for consideration, and not recommende

SUBMITTER: Zhou N 

PROVIDER: S-EPMC6656482 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature